Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.


Journal

Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370

Informations de publication

Date de publication:
12 2022
Historique:
received: 25 06 2022
accepted: 30 08 2022
revised: 25 08 2022
pubmed: 11 10 2022
medline: 29 11 2022
entrez: 10 10 2022
Statut: ppublish

Résumé

Alcohol-associated liver disease (ALD) is one of the most common chronic liver diseases. Its pathological spectrum includes the overlapping stages of hepatic steatosis/steatohepatitis that can progress to liver fibrosis and cirrhosis; both are risk factors for hepatocellular carcinoma. Moreover, ALD diagnosis and management pose several challenges. The early pathological stages are reversible by alcohol abstinence, but these early stages are often asymptomatic, and currently, there is no specific laboratory biomarker or diagnostic test that can confirm ALD etiology. Alcohol consumers frequently show dysregulation of iron and iron-related proteins. Examination of iron-related parameters in this group may aid in early disease diagnosis and better prognosis and management. For this, a coherent overview of the status of iron and iron-related proteins in alcohol consumers is essential. Therefore, here, we collated and reviewed the alcohol-induced alterations in iron and iron-related proteins. Reported observations include unaltered, increased, or decreased levels of hemoglobin and serum iron, increments in intestinal iron absorption (facilitated via upregulations of duodenal divalent metal transporter-1 and ferroportin), serum ferritin and carbohydrate-deficient transferrin, decrements in serum hepcidin, decreased or unaltered levels of transferrin, increased or unaltered levels of transferrin saturation, and unaltered levels of soluble transferrin receptor. Laboratory values of iron and iron-related proteins in alcohol consumers are provided for reference. The causes and mechanisms underlying these alcohol-induced alterations in iron parameters and anemia in ALD are explained. Notably, alcohol consumption by hemochromatosis (iron overload) patients worsens disease severity due to the synergistic effects of excess iron and alcohol.

Identifiants

pubmed: 36214835
doi: 10.1007/s00109-022-02254-8
pii: 10.1007/s00109-022-02254-8
pmc: PMC9691479
doi:

Substances chimiques

Iron E1UOL152H7
Hepcidins 0
Receptors, Transferrin 0
Ethanol 3K9958V90M

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1673-1689

Informations de copyright

© 2022. The Author(s).

Références

J Hepatol. 1995 Oct;23(4):431-9
pubmed: 8655961
Am J Gastroenterol. 2020 Mar;115(3):398-405
pubmed: 31985531
Open Access Maced J Med Sci. 2018 Jun 14;6(6):1010-1016
pubmed: 29983793
Alcohol. 2019 Dec;81:27-30
pubmed: 31233805
Nat Rev Dis Primers. 2018 Aug 16;4(1):16
pubmed: 30115921
J Hepatol. 1992 Sep;16(1-2):122-7
pubmed: 1484146
J Biol Chem. 2002 Oct 25;277(43):41163-70
pubmed: 12183449
Hepatol Int. 2022 Apr;16(2):348-358
pubmed: 35060066
Liver Int. 2020 Jan;40(1):194-204
pubmed: 31444993
Nihon Shokakibyo Gakkai Zasshi. 2020;117(12):1100-1108
pubmed: 33298676
Prim Care Companion CNS Disord. 2020 May 07;22(3):
pubmed: 32391988
World J Gastroenterol. 2007 Oct 7;13(37):4925-30
pubmed: 17854133
BMC Gastroenterol. 2014 May 22;14:97
pubmed: 24885510
J Pak Med Assoc. 2019 Aug;69(8):1170-1175
pubmed: 31431773
J Cell Physiol. 2021 Oct;236(10):7266-7289
pubmed: 33821487
Ann Gastroenterol. 2017;30(4):405-413
pubmed: 28655976
Crit Care. 2019 Mar 9;23(1):81
pubmed: 30850005
Am J Med Sci. 2018 Feb;355(2):183-190
pubmed: 29406047
Gastroenterology. 2004 May;126(5):1293-301
pubmed: 15131790
Biochim Biophys Acta. 2010 Aug;1800(8):760-9
pubmed: 20304033
Am J Epidemiol. 2003 Jul 15;158(2):129-34
pubmed: 12851225
Blood. 2011 Apr 28;117(17):4425-33
pubmed: 21346250
Adv Exp Med Biol. 2015;815:89-112
pubmed: 25427903
PLoS Med. 2022 Jul 14;19(7):e1004039
pubmed: 35834561
Cell Mol Life Sci. 2022 Mar 24;79(4):201
pubmed: 35325321
J Biol Chem. 2001 Mar 16;276(11):7811-9
pubmed: 11113132
Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):189S-93S
pubmed: 16344607
J Cell Mol Med. 2014 Sep;18(9):1840-50
pubmed: 24894955
Sci Rep. 2020 Dec 14;10(1):21926
pubmed: 33318518
Blood Rev. 2009 May;23(3):95-104
pubmed: 18835072
Dig Dis Sci. 1982 Oct;27(10):909-16
pubmed: 7117074
World J Gastroenterol. 2019 Feb 7;25(5):521-538
pubmed: 30774269
World J Emerg Surg. 2020 Jun 30;15(1):41
pubmed: 32605582
Med Sci Monit. 2016 Jun 22;22:2144-51
pubmed: 27332079
J Leukoc Biol. 2004 Mar;75(3):553-9
pubmed: 14634061
Alcohol Res. 2017;38(2):163-171
pubmed: 28988571
Int J Mol Sci. 2021 Apr 15;22(8):
pubmed: 33921027
World J Gastroenterol. 2009 Oct 7;15(37):4638-43
pubmed: 19787826
Alcohol Res Health. 2006;29(4):245-54
pubmed: 17718403
Alcohol Clin Exp Res. 2006 Jan;30(1):106-12
pubmed: 16433737
Biol Trace Elem Res. 2020 Jun;195(2):427-435
pubmed: 31486016
Proc Nutr Soc. 1995 Jul;54(2):501-8
pubmed: 8524896
Adv Clin Chem. 2016;75:71-97
pubmed: 27346617
Cell Metab. 2015 Nov 3;22(5):777-87
pubmed: 26437604
Hepatology. 2020 Jan;71(1):306-333
pubmed: 31314133
Basic Clin Pharmacol Toxicol. 2022 Jan;130(1):182-190
pubmed: 34591374
Mol Biol Cell. 2007 Jul;18(7):2569-78
pubmed: 17475779
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
Clin Exp Med. 2010 Mar;10(1):73-9
pubmed: 19730983
Clin Liver Dis (Hoboken). 2019 May 31;13(5):136-139
pubmed: 31236261
J Clin Invest. 2002 Oct;110(7):1037-44
pubmed: 12370282
Adv Clin Chem. 2018;83:197-225
pubmed: 29304902
J Hepatol. 2022 Aug;77(2):479-502
pubmed: 35662478
Med Sci Monit. 2003 Dec;9(12):RA285-90
pubmed: 14646983
Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1158-65
pubmed: 22732356
Clin Chim Acta. 2016 Aug 1;459:19-24
pubmed: 27221205
Free Radic Biol Med. 2019 Mar;133:46-54
pubmed: 29969719
Am J Dis Child. 1988 Feb;142(2):156-9
pubmed: 3341315
Nutrients. 2012 May;4(5):356-71
pubmed: 22690322
Br J Cancer. 2022 Jul;127(2):185-192
pubmed: 35264787
Clin Exp Med. 2022 Feb 22;:
pubmed: 35192111
Clin J Gastroenterol. 2020 Oct;13(5):882-890
pubmed: 32472376
Gastroenterology. 2002 Feb;122(2):281-9
pubmed: 11832443
BMC Gastroenterol. 2015 Jul 25;15:87
pubmed: 26209440
PLoS One. 2016 Nov 8;11(11):e0165278
pubmed: 27824864
Liver Int. 2016 Feb;36(2):185-8
pubmed: 26561367
J Toxicol Environ Health B Crit Rev. 2004 Jul-Aug;7(4):319-37
pubmed: 15205047
Am J Drug Alcohol Abuse. 2011 Jan;37(1):68-73
pubmed: 21091174
Int J Hepatol. 2012;2012:459278
pubmed: 22121494
J Biol Chem. 2006 Aug 11;281(32):22974-82
pubmed: 16737972
Hepatology. 1985 Sep-Oct;5(5):714-21
pubmed: 4029886
Aliment Pharmacol Ther. 2020 Aug;52(3):537-544
pubmed: 32573823
World J Gastroenterol. 2009 Mar 14;15(10):1186-93
pubmed: 19291818
World J Gastroenterol. 2014 Sep 7;20(33):11684-99
pubmed: 25206273
Alcohol Health Res World. 1997;21(1):42-52
pubmed: 15706762
Ann Hematol. 2009 Jul;88(7):687-94
pubmed: 19039534
Eur J Nutr. 2022 Apr;61(3):1167-1176
pubmed: 34817678
Adv Drug Alcohol Res. 2021 Oct;1:
pubmed: 35169771
J Intern Med. 1994 Sep;236(3):315-22
pubmed: 8077889
Adv Nutr. 2017 Jan 17;8(1):126-136
pubmed: 28096133
Best Pract Res Clin Gastroenterol. 2003 Aug;17(4):575-92
pubmed: 12828956
Liver Transpl. 2018 Mar;24(3):343-351
pubmed: 29149510
Clin Liver Dis (Hoboken). 2021 Jun 04;17(5):365-370
pubmed: 34136143
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S2-8
pubmed: 17331161
Alcohol Clin Exp Res. 2001 Jul;25(7):1037-45
pubmed: 11505030
Int Immunol. 2017 Nov 1;29(9):401-409
pubmed: 28541437
Singapore Med J. 2011 Mar;52(3):175-81
pubmed: 21451926
Clin Lab Haematol. 2003 Dec;25(6):353-7
pubmed: 14641138

Auteurs

Kevin Ferrao (K)

GKT School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Najma Ali (N)

GKT School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Kosha J Mehta (KJ)

Centre for Education, Faculty of Life Sciences and Medicine, King's College London, London, UK. kosha.mehta@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH